Literature DB >> 7848916

Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells.

T Tatsuta1, M Naito, K Mikami, T Tsuruo.   

Abstract

P-glycoprotein (PGP), an active efflux pump of antitumor agents in multidrug-resistant tumor cells, exists in brain capillary endothelium and could be functionally involved in the blood-brain barrier. To study the regulatory mechanism of PGP expression in brain capillary endothelium, various mouse tissue matrices were tested for their abilities to enhance the expression of PGP in mouse brain capillary endothelial cells (MBEC), which express relatively small amounts of PGP. Of the four tissue matrices we examined, PGP expression in MBEC cultured on the brain matrix increased 2.0-fold. The PGP-inducing activity was similarly detected in bovine brain matrix, and the activity was enriched in the fraction of pl 9.0 by isoelectric focusing. The fraction, named PIC-fraction (PGP-inducing component), increased the PGP expression in MBEC 3.5-fold. By Northern blot analysis, a 3.3-fold enhancement of mdr gene expression was observed in MBEC cultured on the PIC-fraction. The PGP-inducing activity of the PIC-fraction was reduced by the treatment with trypsin but not with collagenase, suggesting that a proteinaceous factor distinct from type I collagen might be responsible for the PGP-inducing activity of PIC-fraction. Although the PIC-fraction increased the PGP expression in other mouse brain capillary endothelial cells, the PIC-fraction did not increase PGP expression in mouse aortic endothelial cells and KB carcinoma cell lines expressing various amounts of PGP. These observations suggest that PGP expression in brain capillary endothelium is specifically regulated by a tissue-specific factor in the brain matrix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848916

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

3.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data.

Authors:  H Murakami; N Sawada; N Koyabu; H Ohtani; Y Sawada
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 5.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated.

Authors:  C H Lee
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

7.  The pharmacology of nucleotide receptors on primary rat brain endothelial cells grown on a biological extracellular matrix: effects on intracellular calcium concentration.

Authors:  I Sipos; E Dömötör; N J Abbott; V Adam-Vizi
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

8.  Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells.

Authors:  Shinya Dohgu; Atsushi Yamauchi; Fuyuko Takata; Mikihiko Naito; Takashi Tsuruo; Shun Higuchi; Yasufumi Sawada; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

9.  Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.

Authors:  Shinya Dohgu; Atsushi Yamauchi; Fuyuko Takata; Yasufumi Sawada; Shun Higuchi; Mikihiko Naito; Takashi Tsuruo; Susumu Shirabe; Masami Niwa; Shigeru Katamine; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

10.  P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier.

Authors:  T Miyama; H Takanaga; H Matsuo; K Yamano; K Yamamoto; T Iga; M Naito; T Tsuruo; H Ishizuka; Y Kawahara; Y Sawada
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.